Bausch Health Companies (BHC) Interest Coverage Ratio (2009 - 2026)
Bausch Health Companies' (BHC) quarterly Interest Coverage Ratio came in at 2.36 in Q1 2026, down 382.55% year-on-year from 0.84 in Q1 2025, and down 297.93% quarter-over-quarter from 1.19 in Q4 2025.
Bausch Health Companies (BHC) Interest Coverage Ratio (2009 - 2026) Analysis & Trends
Bausch Health Companies has disclosed Interest Coverage Ratio across 18 years of filings, most recently posting 2.36 for Q1 2026.
- Interest Coverage Ratio for Q1 2026 came in at 2.36, down 382.55% year-over-year; the trailing twelve-month figure through Mar 2026 was 0.35 (down 69.02% YoY), and the FY2025 annual result was 1.13, up 1.48% from the prior year.
- Interest Coverage Ratio came in at 2.36 for Q1 2026 at Bausch Health Companies, down from 1.19 in the prior quarter.
- In the past five years, Interest Coverage Ratio ranged from a high of 1.66 in Q4 2024 to a low of 2.36 in Q1 2026.
- The 5-year median for Interest Coverage Ratio is 0.84 (2025), against an average of 0.62.
- Across the five-year window, Interest Coverage Ratio soared 2125.47% in 2024 and sank 382.55% in 2026, its largest moves.
- Bausch Health Companies' Interest Coverage Ratio stood at 0.77 in 2022, then surged by 229.73% to 1.0 in 2023, then soared by 66.04% to 1.66 in 2024, then fell by 27.89% to 1.19 in 2025, then tumbled by 297.93% to 2.36 in 2026.
- The last three Interest Coverage Ratio figures came in at 2.36 (Q1 2026), 1.19 (Q4 2025), and 1.5 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | - |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 13.44 |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 108.60 |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | - |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 5.39 |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | -2.31 |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 16.72 |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | - |
| 10 | Bausch Health Companies | 1.91 Bn | 1.58 Bn | 2.48 Bn | -2.36 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.36 |
| Dec 31, 2025 | 1.19 |
| Sep 30, 2025 | 1.50 |
| Jun 30, 2025 | 0.95 |
| Mar 31, 2025 | 0.84 |
| Dec 31, 2024 | 1.66 |
| Sep 30, 2024 | 0.92 |
| Jun 30, 2024 | 1.11 |
| Mar 31, 2024 | 0.79 |
| Dec 31, 2023 | 1.00 |
| Sep 30, 2023 | 0.04 |
| Jun 30, 2023 | 1.29 |
| Mar 31, 2023 | 0.57 |
| Dec 31, 2022 | -0.77 |
| Sep 30, 2022 | 0.63 |
| Jun 30, 2022 | 0.39 |
| Mar 31, 2022 | 0.79 |
| Dec 31, 2021 | 1.07 |
| Sep 30, 2021 | 1.64 |
| Jun 30, 2021 | -0.74 |